SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-18-000372
Filing Date
2018-05-02
Accepted
2018-05-02 17:13:48
Documents
1
Period of Report
2018-04-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ss90746_4.html 4  
1 OWNERSHIP DOCUMENT ss90746_4.xml 4 8895
  Complete submission text file 0000947871-18-000372.txt   11145
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 18800695

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 212-749-6400
OrbiMed Capital GP III LLC (Reporting) CIK: 0001432241 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 18800694

Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research